Credit Suisse Reiterates Outperform, Raises Price Target On Mead Johnson Nutrition On Multiple Positive Factors

In a report published Monday, Credit Suisse analyst Robert Moskow reiterated an Outperform rating on

, and raised the price target from $110.00 to $112.00. In the report, Credit Suisse noted, "We are raising our target price on Mead Johnson to $112/share. While the market maintains a rather skeptical stance on the company's ability to navigate slowing trends in China (its lead market), we believe that the business has sufficient tailwinds for positive sales and earnings revisions during the course of the year. This includes a unique body of research and marketing on the benefits of DHA, expanding the toddler milk category in the U.S., and capitalizing on the pent-up demand for babies in the U.S. as domestic economic conditions continue to improve. We are lowering our FY15 and FY16 estimates to $4.06 and $4.55." Mead Johnson Nutrition closed on Friday at $105.01.